A new study has linked Genentech's cancer drug Avastin to a higher rate of deadly side effects, the Wall Street Journal reports. The analysis, conducted by researchers at Stony Brook University ...

A new analysis raises fresh questions about the risks of the blockbuster cancer drug Avastin, suggesting the chance of dying from side effects linked to it is higher than the risk for patients on ...

CHICAGO • A new analysis raises fresh questions about the risks of the blockbuster cancer drug Avastin, suggesting the chance of dying from side effects linked to it is higher than the risk for ...

LONDON, June 11 (Reuters) - Roche's cancer drug Avastin is a cheap, effective treatment for preventing blindness and should be used routinely in countries that cannot afford the far more costly ...

(Reuters) - The U.S. Department of Veterans Affairs said it has stopped using Roche's Avastin to treat a sight-robbing eye disease as it looks into reports of increased risk of infection. Roche's ...

The widely used cancer drug Avastin could save the eyesight of tens of thousands of people with age-related macular degeneration of the wet form, British researchers said Friday. The drug provides an ...

Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly ...